# DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers

**Authors:** Sören Schnellhardt, Simon Böke, Silke Tribius, Mechthild Krause, Marlen Haderlein, Alexander Rühle, Christoph Süß, Annett Linge, Markus Hecht, Panagiotis Balermpas

PMC · DOI: 10.1007/s00066-026-02511-6 · 2026-02-17

## Full-text entities

- **Diseases:** head and neck cancers (MESH:D006258)

---
Source: https://tomesphere.com/paper/PMC12999596